StockNow
Log in
Global Markets

European Movers: AstraZeneca (AZN LN) +1.3%, Glencore (GLEN LN) +2.3%, Sandoz (SDZ SW) +3%, Argenx (ARGX BB) +8.2%

StockNow breaking-news AI analysis

Positive clinical trial results for Argenx and AstraZeneca, alongside a $1 billion copper supply loan for Glencore and a biosimilar deal for Sandoz, drove European market gains on August 17, 2026.

2 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

Yemeni government forces say Houthi militias launched a new attack with two missiles in Bab al-Mandab, Al Hadath reports

Market Analysis

[ANALYSIS] US-Iran MoU lapses today: Expiry does not automatically trigger a resumption of hostilities

U.S. Markets

Apple (AAPL) is said to unveil a foldable iPhone alongside the next generation iPhone 18 series on September 9th according to Taiwanese press

AAPL